Prestige Consumer Healthcare (PBH) Debt to Equity (2016 - 2024)
Prestige Consumer Healthcare has reported Debt to Equity over the past 14 years, most recently at $0.68 for Q1 2024.
- For Q1 2024, Debt to Equity fell 26.86% year-over-year to $0.68; the TTM value through Mar 2024 reached $0.68, down 26.86%, while the annual FY2024 figure was $0.68, 26.86% down from the prior year.
- Debt to Equity for Q1 2024 was $0.68 at Prestige Consumer Healthcare, down from $0.93 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.48 in Q1 2020 and troughed at $0.0 in Q3 2021.
- A 5-year average of $0.99 and a median of $1.09 in 2021 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: tumbled 99.66% in 2021 and later dropped 0.64% in 2023.
- Year by year, Debt to Equity stood at $1.17 in 2020, then crashed by 99.65% to $0.0 in 2021, then soared by 22701.91% to $0.94 in 2022, then fell by 0.64% to $0.93 in 2023, then fell by 26.86% to $0.68 in 2024.
- Business Quant data shows Debt to Equity for PBH at $0.68 in Q1 2024, $0.93 in Q1 2023, and $0.94 in Q1 2022.